Back to Results
First PageMeta Content
Amgen / Growth factors / Cancer treatments / Febrile neutropenia / Filgrastim / Chemotherapy / Neutropenia / Fentanyl / Duragesic / Medicine / Oncology / Pegfilgrastim


Bulletin #818 October 12, 2011 NBPDP FORMULARY UPDATE
Add to Reading List

Document Date: 2011-10-11 14:27:45

Open Document

File Size: 217,27 KB

Share Result on Facebook

Company

Amgen Canada / STI Technologies Limited / NVR / /

/

IndustryTerm

program using smartcard technology / /

MedicalCondition

neutropenias / febrile neutropenia / chronic non-malignant pain / profound neutropenia / neutropenia / cancer receiving myelosupressive chemotherapy / neutropenic sepsis / /

MedicalTreatment

Chemotherapy / oral therapy / /

/

Product

Telmisartan / Neulasta / Vagifem / Estradiol / Duragesic / Fentanyl / Micardis / Neupogen / hydrochlorothiazide / /

ProvinceOrState

New Brunswick / /

PublishedMedium

the Bulletin / /

Technology

transplantation / program using smartcard technology / Chemotherapy / /

URL

www.gnb.ca/0051/0212/index-e.asp / /

SocialTag